Terms: = Skin cancer AND ERCC4, XPF, 2072, ENSG00000175595, Q92889 AND Prognosis
4 results:
1. Molecular analysis directs the prognosis, management and treatment of patients with xeroderma pigmentosum.
Lehmann AR; Fassihi H
DNA Repair (Amst); 2020 Sep; 93():102907. PubMed ID: 33087273
[TBL] [Abstract] [Full Text] [Related]
2. XPC (A2920C), xpf (T30028C), TP53 (Arg72Pro), and GSTP1 (Ile105Val) polymorphisms in prognosis of cutaneous melanoma.
Gomez GV; de Oliveira C; Rinck-Junior JA; de Moraes AM; Lourenço GJ; Lima CS
Tumour Biol; 2016 Mar; 37(3):3163-71. PubMed ID: 26427666
[TBL] [Abstract] [Full Text] [Related]
3. xpf protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: suitability as a biomarker for patient selection.
Hatch SB; Swift LP; Caporali S; Carter R; Hill EJ; MacGregor TP; D'Atri S; Middleton MR; McHugh PJ; Sharma RA
Int J Cancer; 2014 Mar; 134(6):1495-503. PubMed ID: 23982883
[TBL] [Abstract] [Full Text] [Related]
4. Polymorphisms of nucleotide excision repair genes predict melanoma survival.
Li C; Yin M; Wang LE; Amos CI; Zhu D; Lee JE; Gershenwald JE; Grimm EA; Wei Q
J Invest Dermatol; 2013 Jul; 133(7):1813-21. PubMed ID: 23407396
[TBL] [Abstract] [Full Text] [Related]
